2025-01-30 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Review

**1. Performance Relative to S&P 500 (VOO):**

UnitedHealth Group Inc. (UNH) is a diversified healthcare company offering a range of health benefits programs, including health insurance, Medicare and Medicaid plans, and other health services.

The cumulative return of UNH (148.19%) significantly outperforms the S&P 500 (VOO) cumulative return of 119.94%.  The difference is 28.3%, placing it in the 90th percentile (23.2% relative to historical volatility) of its past performance relative to the S&P 500.  This suggests UNH has historically outperformed the market. However, it's crucial to remember that past performance is not indicative of future results.

The provided Alpha and Beta analysis shows consistently positive alpha (outperformance relative to the market) over multiple years.  The Beta, however, indicates significant market sensitivity (higher than 1), particularly in recent periods reflecting market volatility.


**2. Recent Price Movement:**

* **Closing Price:** $538.10
* **5-Day Moving Average:** $537.28
* **20-Day Moving Average:** $524.20
* **60-Day Moving Average:** $551.22

The price is slightly below the 5-day moving average, suggesting a minor recent downturn. However, it's above the 20-day moving average, indicating a potential short-term upward trend, while it's also below the 60-day moving average, suggesting a potential longer-term downward trend. The recent price change (-$0.81) reflects a minor decrease compared to the previous close.


**3. Technical Indicators and Expected Return:**

* **RSI:** 59.87 (Slightly below the overbought threshold of 70, indicating neither overbought nor oversold conditions).
* **PPO:** 0.72 (Positive, suggesting bullish momentum).
* **20-Day Relative Strength Change:** +7.3 (Indicates a recent short-term upward trend).
* **Expected Return (2+ years):** 260.5% (This represents a significant expected outperformance relative to the S&P 500 over the long term. This number should be treated with significant caution; long-term projections are inherently uncertain).


**4. Recent Earnings Analysis:**

The earnings data shows some volatility.  While Q4 2024 shows strong EPS and revenue growth, Q2 2024 shows a significant drop in EPS.  It's important to investigate the reasons behind this fluctuation (e.g., seasonal factors, one-time events) before drawing conclusions. Consistent revenue growth is observed over the period.  A more detailed analysis including year-over-year and quarter-over-quarter comparisons would be necessary for a complete evaluation.  The duplication of the 2024-11-04 data point needs to be clarified.


**5. Financial Information:**

* **Revenue:**  Shows consistent revenue growth over the past year, with minor fluctuations from quarter to quarter.
* **Profit Margin:** Generally high and stable, though showing a slight downward trend from Q3 2023 to Q2 2024.
* **Equity:**  Shows growth though with some volatility.
* **ROE:** Shows substantial fluctuation, and includes a negative value in Q1 2024.  Further investigation into the cause is required.


**7. Overall Analysis:**

UNH has historically outperformed the S&P 500, showcasing consistent positive alpha.  Recent price action suggests a minor short-term dip but a potential upward trend remains. Technical indicators show neither overbought nor oversold conditions with a generally positive momentum.  Earnings show strong revenue growth, but EPS volatility necessitates further analysis.  Financial information indicates high profitability, though recent ROE figures demonstrate some cause for concern.  The projected long-term outperformance should be viewed with caution due to the inherent uncertainty involved in such projections.  A comprehensive analysis requires investigation into the reasons for EPS and ROE volatility and a deeper dive into the company's financial statements and future outlook.


**8. Disclaimer:** This analysis is for informational purposes only and should not be considered financial advice.  Investing involves risk, and past performance is not indicative of future results.  Consult with a financial professional before making any investment decisions.
